drugset / Trial / NCT03155932
Safety, Tolerability, and Efficacy of Etrasimod (APD334) in Participants With Primary Biliary Cholangitis
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this open-label, pilot, proof of concept study is to evaluate the safety, tolerability, and efficacy of oral etrasimod (APD334) in participants with primary biliary cholangitis (PBC).
Timeline
- Start
- 2017-12-29
- Primary completion
- 2019-01-31
- Completion
- 2019-01-31
Outcome
Outcome not reported
Stopped (Business): “Sponsor decision”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Etrasimod | Small molecule | — | Oral |